Advanced search
Publication Cover
Cancer Management and Research Volume 12, 2020 - Issue
Submit an article Journal homepage
124
Views
16
CrossRef citations to date
0
Altmetric
Original Research

MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT

Lingyu Qian1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China;2 Department of Oncology, Rudong Peoples’ Hospital of Jiangsu Province, Nantong, People’s Republic of China
,
Fangcen Liu3 Department of Pathology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, People’s Republic of China
,
Yanhong Chu1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China
,
Qingqing Zhai1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China
,
Xiao Wei3 Department of Pathology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, People’s Republic of China
,
Jie Shao1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China
,
Rutian Li1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China
,
Qiuping Xu1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China
,
Lixia Yu1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China
,
Baorui Liu1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China
&
Qin Liu1 The Comprehensive Cancer Centre of Drum Tower Hospital, Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 12215-12223 | Published online: 27 Nov 2020

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jianjun Yuan, Yan Liu, Quan Zhang, Zhishuai Ren, Guang Li & Rong Tian. (2021) CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760. Cancer Management and Research 13, pages 4433-4445.
Read now

Articles from other publishers (15)

Zaigang Zhou, Haoxiang Wang, Jie Li, Xin Jiang, Zhangping Li & Jianliang Shen. (2024) Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review. International Journal of Biological Macromolecules 254, pages 127911.
Crossref
Tong Hu, Run Shi, Yunru Gu, Hanyu Zhou, Yuan Fang, Tingting Xu, Yangyue Xu, Xi Wu, Ling Ma & Yongqian Shu. (2023) Cancer‐derived non‐coding RNAs endow tumor microenvironment with immunosuppressive properties . WIREs RNA 15:1.
Crossref
Jun Gao, Huaqiao Wang, Xiujuan Qiu & Jianjun Tang. (2023) E2F3/CDCA2 reduces radiosensitivity in gastric adenocarcinoma by activating PI3K/AKT pathway. The British Journal of Radiology 96:1152.
Crossref
Seung-Hyun Yang, Hye Young Son, Mirae Park, Hyun Wook Rho, Hwunjae Lee & Yong-Min Huh. (2023) Inhibition of PD-L1 and tumor growth in triple-negative breast cancer using a magnetic nanovector with microRNA34a. Cancer Nanotechnology 14:1.
Crossref
Ameer S. Sahib, Amjid Fawzi, Rahman S. Zabibah, Nisar Ahmad Koka, Shaymaa Abdulhameed Khudair, Faris Anad Muhammad & Doaa A. Hamad. (2023) miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers. Cellular Signalling 112, pages 110881.
Crossref
Nhat-Chau TRUONG, Nhi-Thao HUYNH, Kmuong-Duy PHAM & Phuc-Van PHAM. (2023) Roles of cancer stem cells in cancer immune surveillance. Minerva Biotechnology and Biomolecular Research 35:1.
Crossref
T.N. Sotnikova, T.V. Polushkina & N.V. Danilova. (2023) Relationship between PD-L1 expression and tumor stem cell marker CD44 as a promising basis for the development of new approaches to cancer targeted therapy. Arkhiv patologii 85:6, pages 70.
Crossref
John G. Yuen, Andrew Fesler, Ga-Ram Hwang, Lan-Bo Chen & Jingfang Ju. (2022) Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics. Molecular Therapy 30:11, pages 3450-3461.
Crossref
Roberta Giordo, Zena Wehbe, Panagiotis Paliogiannis, Ali H. Eid, Arduino A. Mangoni & Gianfranco Pintus. (2022) Nano-targeting vascular remodeling in cancer: Recent developments and future directions. Seminars in Cancer Biology 86, pages 784-804.
Crossref
Henry Marles & Adrian Biddle. (2022) Cancer stem cell plasticity and its implications in the development of new clinical approaches for oral squamous cell carcinoma. Biochemical Pharmacology 204, pages 115212.
Crossref
Fatimat Kipkeeva, Tatyana Muzaffarova, Alexandra Korotaeva, Danzan Mansorunov, Pavel Apanovich, Maxim Nikulin, Olga Malikhova, Ivan Stilidi & Alexander Karpukhin. (2022) The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer. International Journal of Molecular Sciences 23:16, pages 9324.
Crossref
Tuan Hiep Tran & Thi Thu Phuong Tran. (2022) Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology. Royal Society Open Science 9:4.
Crossref
Huihao Qin, Xing Li, Wei Zhang & Zhiqiang Ding. (2022) LncRNA OGFRP1 promotes cell proliferation and suppresses cell radiosensitivity in gastric cancer by targeting the miR-149-5p/MAP3K3 axis. Journal of Molecular Histology 53:2, pages 257-271.
Crossref
Saumya Nigam, Jack Owen Bishop, Hanaan Hayat, Tahnia Quadri, Hasaan Hayat & Ping Wang. (2022) Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances. Pharmaceutics 14:3, pages 644.
Crossref
Ga-Ram Hwang, John G. Yuen & Jingfang Ju. (2021) Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development. International Journal of Molecular Sciences 22:4, pages 1624.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.